# FDA Inspection 1021880 - Vitalant - July 26, 2017

Source: https://www.keypedia.com/records/fda_inspections/vitalant/64c171f9-c1a0-4d68-8a18-ac7509c4aa40
Source feed: FDA_Inspections

> FDA Inspection 1021880 for Vitalant on July 26, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1021880
- Company Name: Vitalant
- Inspection Date: 2017-07-26
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1270494 - 2025-04-25](https://www.keypedia.com/records/fda_inspections/vitalant/8d3486a1-36f5-4080-8629-ca56bc30ea57)
- [FDA Inspection 1270494 - 2025-04-25](https://www.keypedia.com/records/fda_inspections/vitalant/15f44f19-7d3d-4ccd-9d42-10683f4e932b)
- [FDA Inspection 1088441 - 2019-05-01](https://www.keypedia.com/records/fda_inspections/vitalant/1415cbae-1688-48d4-874b-220a2f7a1192)
- [FDA Inspection 903680 - 2014-11-04](https://www.keypedia.com/records/fda_inspections/vitalant/6ad104a7-0c8e-4841-88b3-8914dea1aec4)
- [FDA Inspection 809353 - 2012-12-05](https://www.keypedia.com/records/fda_inspections/vitalant/c1b5ddab-2820-45bd-ae4c-c4f3295d865b)

Company: https://www.keypedia.com/companies/vitalant/2d532726-441a-4ec8-8c97-93d7b64b8359

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d